The full Johnson & Johnson (JNJ) reaction history

JNJ news moved a median of +0.03% by the close. Every JNJ news event with the realized, point-in-time move the market made — the same measurement, headline by headline. Back to the JNJ overview →

Half of the 481 JNJ news events with a measured close landed between -0.58% and +0.54%; 51% closed up.

By year and event type

JNJ reaction counts across 4 years.

Event type2026202520242023Total
Press release11015212114397
SEC filing · Form 8-K81112536
SEC filing · Form 13F-HR544114
SEC filing · Form 10-Q333110
SEC filing · Form 11-K11204
SEC filing · Form DEFA14A11204
SEC filing · Form 10-K11103
SEC filing · Form ARS11103
SEC filing · Form DEF11103
SEC filing · Form N-PX11103
SEC filing · Form SD11103
SEC filing · Form 8-A12B01102
SEC filing · Form CERT01102
SEC filing · Form S-3ASR10001
All types13417915121485

Counts from the full measured window for JNJ, not just the free rows below — every event type we have labeled, year by year.

Archive pages

Older JNJ news pages.

Page 1 is the JNJ overview; pages 2–10 carry the rest of the measured list.

The 10 most recent JNJ reactions.

DateHeadlineEventSource5-minTo close
Bronstein, Gewirtz & Grossman, LLC Is Investigating Johnson & Johnson (JNJ) And Encourages Stockholders to ConnectPress releaseACCESS Newswire-0.04%+0.62%
Form 10-Q JOHNSON & JOHNSON For: Sep 27SEC filing · Form 10-QSEC EDGAR——
Johnson & Johnson (JNJ) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the InvestigationPress releaseACCESS Newswire+0.04%+0.08%
Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in HalfPress releaseBusiness Wire+0.69%+0.73%
Johnson & Johnson announces new data showing TREMFYA® (guselkumab) is the only IL-23 to deliver durable fistula remission through 48 weeks in Crohn's disease with perianal fistulaPress releasePR Newswire+0.29%-0.25%
JNJ Investors with $100,000 in Losses Have Opportunity to Join Johnson & Johnson Fraud Investigation with SBS LawPress releaseBusiness Wire+0.29%-0.25%
After 20 Years, AdVenture Games Is Reintroducing Team Building as an Experience Worth RememberingPress releasePR Web+1.68%-1.51%
Form 8-K JOHNSON & JOHNSON For: Oct 13SEC filing · Form 8-KSEC EDGAR+0.03%-2.08%
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026Press releaseBusiness Wire+0.03%-2.08%
Johnson & Johnson reports Q3 2026 results, raises 2026 guidancePress releaseBusiness Wire+0.03%-2.08%

475 more JNJ reactions are behind a free account. Create one to see all 485 measured JNJ events — the same point-in-time reactions, every headline.

See all 485 JNJ events →

No credit card · 100 free credits/mo

Keep exploring

More JNJ: earnings → · analyst actions → · SEC filings → · JNJ overview →

Other Health Care names, measured the same way

TickerEventsMedian 30-min% positive
Eli Lilly (LLY)2,000++0.03%52%
UnitedHealth Group (UNH)2,000+-0.03%48%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.